Yonghe Medical FY26 H1 net profit more than doubles to RMB 75.5 million; revenue rises 13.8% to RMB 980.6 million

• Yonghe Medical posted revenue of RMB 980.6 million, up 13.8%, as net profit more than doubled to RMB 75.5 million.
• Basic earnings per share rose to RMB 0.15; EBITDA climbed 29.2% to RMB 219.5 million.
• Gross margin widened 5.1 percentage points to 69% as gross profit rose 23% to RMB 676.9 million.
• Hair transplant revenue increased 12.3% to RMB 743.3 million; surgery consumers rose 21.8% to 40,793 while average spending fell to RMB 18,222.
• Interim dividend not declared; cash, cash equivalents and term deposits rose to RMB 883.6 million with no bank borrowings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yonghe Medical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12292521), on August 20, 2026, and is solely responsible for the information contained therein.